Future liver remnant growth after various portal vein embolization regimens: a quantitative comparison

References

• Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–785.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197:686–690.
   PubMed Web of Science ®Google Scholar
• Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol. 2006;13:58–65.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Nordlinger B, Cervantes A, et al. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol. 2010;21:v93–v97.
   PubMed Web of Science ®Google Scholar
• Malinowski M, Geisel D, Stary V, et al. Portal vein embolization with plug/coils improves hepatectomy outcome. J Surg Res. 2015;194:202–211.
   PubMed Web of Science ®Google Scholar
• Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–309.
   PubMed Web of Science ®Google Scholar
• Schroeder RA, Marroquin CE, Bute BP, et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243:373–379.
   PubMed Web of Science ®Google Scholar
• Gur I, Diggs BS, Wagner JA, et al. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy. J Gastrointest Surg. 2013;17:2133–2142.
   PubMed Web of Science ®Google Scholar
• de Baere T, Denys A, Madoff DC. Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol. 2007;10:67–78.
   PubMedGoogle Scholar
• Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–527.
   PubMed Web of Science ®Google Scholar
• Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration. J Am Coll Surg. 2003;197:634–659.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Soued M, Grunfeld C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun. 1988;153:576–582.
   PubMed Web of Science ®Google Scholar
• Koga M, Ogasawara H. Induction of hepatocyte mitosis in intact adult rat by interleukin-1 alpha and interleukin-6. Life Sci. 1991;49:1263–1270.
   PubMed Web of Science ®Google Scholar
• Abdalla EK. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol. 2010;102:960–967.
   PubMed Web of Science ®Google Scholar
• Ameli-Renani S, Pavlidis V, Morgan RA. Early and midterm outcomes after transcatheter embolization of type I endoleaks in 25 patients. J Vasc Surg. 2017;65:346–355.
   PubMed Web of Science ®Google Scholar
• Sadeh-Gonike U, Magand N, Armoiry X, et al. Transarterial onyx embolization of intracranial dural fistulas: a prospective cohort, systematic review, and meta-analysis. Neurosurgery. 2018;82:854–863.
   PubMed Web of Science ®Google Scholar
• Massimino KP, Kolbeck KJ, Enestvedt CK, et al. Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy. HPB (Oxford). 2012;14:14–19.
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8:233–240.
   PubMed Web of Science ®Google Scholar
• Fischman AM, Ward TJ, Horn JC, et al. Portal vein embolization before right hepatectomy or extended right hepatectomy using sodium tetradecyl sulfate foam: technique and initial results. JVIR. 2014;25:1045–1053.
   Google Scholar
• Guiu B, Bize P, Gunthern D, et al. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol. 2013;36:1306–1312.
   PubMed Web of Science ®Google Scholar
• Bent CL, Low D, Matson MB, et al. Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. Cardiovasc Intervent Radiol. 2009;32:471–477.
   PubMed Web of Science ®Google Scholar
• Smits MLJ, Vanlangenhove P, Sturm EJC, et al. Transsinusoidal portal vein embolization with ethylene vinyl alcohol copolymer (Onyx): a feasibility study in pigs. Cardiovasc Intervent Radiol. 2012;35:1172–1180.
   PubMed Web of Science ®Google Scholar
• Ne R, Chevallier O, Falvo N, et al. Embolization with ethylene vinyl alcohol copolymer (Onyx((R))) for peripheral hemostatic and non-hemostatic applications: a feasibility and safety study. Quant Imaging Med Surg. 2018;8:280–290.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Hirohashi K, Kubo S, et al. Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization. J Gastroenterol. 1999;34:100–104.
   PubMed Web of Science ®Google Scholar
• Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 2008;12:297–303.
   PubMed Web of Science ®Google Scholar
• Broering DC, Hillert C, Krupski G, et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg. 2002;6:905–913.
   PubMed Web of Science ®Google Scholar
• Gnutzmann D, Kortes N, Sumkauskaite M, et al. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments. Minim Invasive Ther Allied Technol. 2018;27:69–80.
   PubMed Web of Science ®Google Scholar
• EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
   PubMed Web of Science ®Google Scholar
• Kloeckner R, Ruckes C, Kronfeld K, et al. Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial. Trials. 2014;15:311.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Sakamoto Y, Yamamoto S, et al. Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Ann Surg Oncol. 2017;24:1557–1568.
   PubMed Web of Science ®Google Scholar
• Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. JCO. 2011;29:1083–1090.
   PubMed Web of Science ®Google Scholar
• Narita M, Oussoultzoglou E, Jaeck D, et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98:1463–1475.
   PubMed Web of Science ®Google Scholar
• Madoff DC. Portal vein embolization: the continued search for the ideal embolic agent. J Vasc Interv Radiol. 2014;25:1053–1055.
   PubMed Web of Science ®Google Scholar
• Kishi Y, Madoff DC, Abdalla EK, et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery. 2008;144:744–751.
   PubMed Web of Science ®Google Scholar
• Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–414.
   PubMed Web of Science ®Google Scholar
• Eshmuminov D, Raptis DA, Linecker M, et al. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br J Surg. 2016;103:1768–1782.
   PubMed Web of Science ®Google Scholar
• Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016;26:4259–4267.
   PubMed Web of Science ®Google Scholar
• Deipolyi AR, Zhang YS, Khademhosseini A, et al. Portal vein embolization: impact of chemotherapy and genetic mutations. JCM. 2017;6:26.
   Google Scholar
• Spelt L, Sparrelid E, Isaksson B, et al. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. Hpb. 2015;17:529–535.
   PubMed Web of Science ®Google Scholar
• Sturesson C, Keussen I, Tranberg KG. Prolonged chemotherapy impairs liver regeneration after portal vein occlusion – An audit of 26 patients. Eur J Surg Oncol. 2010;36:358–364.
   PubMed Web of Science ®Google Scholar
• de Baere T, Teriitehau C, Deschamps F, et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17:2081–2089.
   PubMed Web of Science ®Google Scholar